In this episode of Clinical Lab Chat, Director of Business Intelligence Chris Wolski interviews Jeff Andrews, MD, FRCSC, a board-certified gynecologist and vice president of Global Medical Affairs for Diagnostic Solutions at BD, what HPV sample self-collection means for the diagnosis, prevention, and treatment of HPV and cervical cancer.   Among the topics they cover in this wide-ranging interview: How HPV sample self-collection will improve testing and treatment access.The importance of...

In this edition of Clinical Lab Chat, Director of Business Intelligence Chris Wolski discusses with Courtney Noah, PhD, VP of Scientific Affairs at BioIVT, how blood-based biofluid testing is poised to revolutionize cancer diagnostics. Among the topics they dig into are: The benefits of blood-based biofluid testing over traditional, more invasive methods.How biofluid testing saves money and improves access for patients.How labs can add blood-based biofluid testing onto their diagnostic...

In this episode of Clinical Lab Chat, CLP’s director of business intelligence, Chris Wolski, discusses how point-of-care testing improves access to both diagnostics and treatment with Seth Egan, co-founder of and chief commercialization officer for Co-Diagnostics.   Among the topics they cover in their wide-ranging conversation: How and why point-of-care testing improves both diagnostic and treatment access.The key equation of simplicity, cost, and turnaround time (TAT) as the means of...

In this edition of Clinical Lab Chat, CLP’s director of business intelligence, Chris Wolski, interviews Nathan Montgomery, MD, PhD, vice president of medical services at NeoGenomics, about how AI will transform laboratory practices including: The role AI plays in eliminating mundane tasks in the lab, making workflows more efficient.The best practices to follow when implementing AI in your clinical laboratory.How AI is transforming the digital pathology landscape.Why and how regulation needs...

In this edition of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, interviews Alessio Travaglia, PhD, PMP, director, Translational Science, Neuroscience, at the Foundation for the National Institutes of Health (FNIH).   The wide-ranging interview tackles all aspects of Alzheimer’s testing and treatment, including: Why traditional methods of Alzheimer’s testing are expensive, invasive, and limit access.The benefits of blood-based biomarkers for Alzheimer’s...

In this wide-ranging episode of Clinical Lab Chat, CLP’s director of business intelligence, Chris Wolski, discusses the hows and whys of keeping kids engaged in science with Natalie Kuldell, executive director of BioBuilder (biobuilder.org), a 501c3 non-profit designed to inspire kids and help teachers and professionals keep students interested in science in school and beyond. Kuldell, who was named as a STEM trailblazer in 2020, is also a member of the MIT faculty.  Among the topics...

In this episode of Clinical Lab Chat, Director of Business Intelligence Chris Wolski presents Jeremy Stackawitz, CEO of Senzo, a challenge—is it possible to create a “perfect” diagnostic test? Using the WHO’s A.S.S.U.R.E.D. criteria, Stackawitz discusses: The operating premise of the criteriaHow testing is evolving to provide more point-of-care optionsHow Senzo is using the A.S.S.U.R.E.D. criteria to develop testsWhat the next few decades will look like in meeting the criteria  And, yes,...

After being declared eradicated in the U.S. in 2000, measles has been making a comeback in recent years—the current caseload equals the entire number of cases in 2023. In this wide-ranging discussion, CLP’s director of business intelligence, Chris Wolski, and Rodney Rohde, PhD, Regents’ Professor in the Texas State University System, a University Distinguished Professor and Chair for the Medical Laboratory Science (MLS) Program in the College of Health Professions at Texas State University,...

In this episode of Clinical Lab Chat, CLP’s director of business intelligence, Chris Wolski, sits down with OpentronsCEO Jonathan Brennan-Badal to discuss all things robotic. In their wide-ranging discussion, they touch on: The trends in clinical laboratory robotsHow to make a use case for adding robots to your labHow to plan for automationThe challenges with laboratory roboticsWhat to expect in the next 5 to 10 years

In this episode of Clinical Lab Chat, CLP Director of Business Intelligence Chris Wolski interviews BD’s Bridget Bagnato about the company’s new MiniDraw technology, and how it is delivering on the promise of Theranos’ failed technology, what it means for access, and how it could be a major paradigm shift in the way patients’ blood specimens are collected and the form in which labs receive them. 

In the latest edition of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, interviews Sara Naseri, MD, co-founder and CEO of women’s health company, Qvin (qvin.com), about the Q-Pad, an FDA-cleared menstrual pad designed to collect blood to be processed for diagnostic purposes. In this wide-ranging discussion, Naseri and Wolski discuss how she came up with this unique, out-of-the-box idea; how the company plans to overcome the taboos associated with menstruation; how...

In this episode of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, spoke with Judit Giró Benet, co-founder and CEO of The Blue Box, for an in-depth discussion on breast cancer diagnostics, with a focus on non-invasive testing. Topics touched on during their conversation include: Using urine to identify breast cancer biomarkers The distinctions between mammographies and liquid biopsies for cancer detection  The importance of accessibility for breast cancer...

In this episode of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, interviews Jessica Murphy, MLS(ASCP)CM, senior technical laboratory educator for Thermo Fisher Scientific. Among the topics they tackled: Why there has been an increased prevalence of food allergies among the U.S. population in the past few decades. How home testing has helped to revolutionize allergy identification—and its potential clinical pitfalls. Why primary care physicians are on the allergy...

In this episode of Clinical Lab Chat, Chris Wolski, CLP’s director of Business Intelligence, David West, CEO of Proscia, and Lou Welebob, vice president and general manager of pathology at Agilent, take a deep dive into the big challenges facing clinical labs today, including workforce shortages, scaling lab operations, and reimbursement, along with some of their solutions, including increased automation, agnostic platforms, and more coherent reimbursement coordination with regulatory agencies.

In the latest episode of Clinical Lab Chat, CLP’s director of business intelligence, Chris Wolski, has a wide-ranging discussion with Jeff Andrews, MD, FRCSC, vice president of Medical Affairs for BD, about BD’s recent STI health survey and what the findings mean for women’s health and their access to care. They also discuss the poor state of medical health education in the U.S., solutions that can help healthcare providers more efficiently test women for sexually transmitted infections, and...

In this episode of Clinical Lab Chat, Chris Wolski and his guest, medical lead at Hurdle, Alex Owens, MD, MPH, discuss the reasons for the rise of at-home testing during COVID, how at-home test improves healthcare access, and the win-win-win it brings to clinical laboratories.

In this episode of Clinical Lab Chat, Chris Wolski meets the Texas A&M team behind what could be an effective, highly sensitive test for Lyme disease. Artem Rogovskky, PhD, ACVM, and Dmitry Kurouski, PhD, outline why Lyme disease is a diagnostic challenge and their work on developing a Lyme disease test using Raman spectroscopy.

During the latest installment of Clinical Lab Chat, CLP Director of Business Intelligence Chris Wolski and Prasanth Perugupalli, chief product officer for Pramana, tackle why there have been delays in pathology labs adopting digital solutions, the business case for digital pathology, how it can change laboratory workflows, and what the future holds for digital pathology.

There are a number of challenges facing clinical laboratories today. Perhaps, the biggest is the ongoing laboratorian shortage. In this episode of Clinical Lab Chat, CLP’s Director of Business Intelligence Chris Wolski interviews Jim Payne, Medical Lab Assisting & Phlebotomy instructor at WEMOCO, Rochester, NY, about the successful high school program he has developed that prepares students for a career in the lab—with many of his students leaving the classroom for a lab bench the day...

In this special edition of Clinical Lab Chat, sponsored by Sysmex America, Inc., CLP’s Director of Business Intelligence, Chris Wolski, does a deep dive into lab QA & QC best practices with Daniel Johnson, assistant director of marketing for Informatics & Service at Sysmex America, Inc. Among the topics they discuss are how to make QA and QC into a preventative and predictive programs instead of reactive tasks, the importance of data with QA and QC workflows, and the one thing Dan...

In the wake of the U.S. Supreme Court’s overturning of Roe v. Wade, there’s been a lot of focus on how it’s affecting the delivery of health care, but one area that hasn’t been as focused on is what this decision means for pre-natal testing and how labs and providers of tests need to be navigating this new landscape. In this episode of Clinical Lab Chat, Director of Business Intelligence Chris Wolski interviews Mitera Co-founder and CEO Saman Askari about the state of pre-natal testing and...

Of all the changes caused by the COVID-19 pandemic, the evolution of POC and home testing is perhaps the biggest. CLP Director of Business Intelligence Chris Wolski and Hamid Erfanian, CEO of Enzo Biochem, an integrated healthcare company focused on offering life sciences, including reagents, clinical testing and molecular diagnostic products, do a deep dive on the history of POC testing, how and why it became ubiquitous during COVID-19, and what this ubiquity means for the future of the...